263 related articles for article (PubMed ID: 33237575)
1. DNA Methylation Profiling of Human Hepatocarcinogenesis.
Hernandez-Meza G; von Felden J; Gonzalez-Kozlova EE; Garcia-Lezana T; Peix J; Portela A; Craig AJ; Sayols S; Schwartz M; Losic B; Mazzaferro V; Esteller M; Llovet JM; Villanueva A
Hepatology; 2021 Jul; 74(1):183-199. PubMed ID: 33237575
[TBL] [Abstract][Full Text] [Related]
2. Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma.
Rizzo F; Rinaldi A; Marchese G; Coviello E; Sellitto A; Cordella A; Giurato G; Nassa G; Ravo M; Tarallo R; Milanesi L; Destro A; Torzilli G; Roncalli M; Di Tommaso L; Weisz A
Oncotarget; 2016 Aug; 7(34):54650-54661. PubMed ID: 27429044
[TBL] [Abstract][Full Text] [Related]
3. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis.
Jee BA; Choi JH; Rhee H; Yoon S; Kwon SM; Nahm JH; Yoo JE; Jeon Y; Choi GH; Woo HG; Park YN
Cancer Res; 2019 Nov; 79(21):5500-5512. PubMed ID: 31506333
[TBL] [Abstract][Full Text] [Related]
5. Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis.
Um TH; Kim H; Oh BK; Kim MS; Kim KS; Jung G; Park YN
J Hepatol; 2011 May; 54(5):939-47. PubMed ID: 21145824
[TBL] [Abstract][Full Text] [Related]
6. Central role of c-Myc during malignant conversion in human hepatocarcinogenesis.
Kaposi-Novak P; Libbrecht L; Woo HG; Lee YH; Sears NC; Coulouarn C; Conner EA; Factor VM; Roskams T; Thorgeirsson SS
Cancer Res; 2009 Apr; 69(7):2775-82. PubMed ID: 19276364
[TBL] [Abstract][Full Text] [Related]
7. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
8. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.
Nault JC; Calderaro J; Di Tommaso L; Balabaud C; Zafrani ES; Bioulac-Sage P; Roncalli M; Zucman-Rossi J
Hepatology; 2014 Dec; 60(6):1983-92. PubMed ID: 25123086
[TBL] [Abstract][Full Text] [Related]
9. Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver.
Di Gioia S; Bianchi P; Destro A; Grizzi F; Malesci A; Laghi L; Levrero M; Morabito A; Roncalli M
BMC Cancer; 2006 Apr; 6():89. PubMed ID: 16606445
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis.
Czauderna C; Poplawski A; O'Rourke CJ; Castven D; Pérez-Aguilar B; Becker D; Heilmann-Heimbach S; Odenthal M; Amer W; Schmiel M; Drebber U; Binder H; Ridder DA; Schindeldecker M; Straub BK; Galle PR; Andersen JB; Thorgeirsson SS; Park YN; Marquardt JU
JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34375307
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis.
Kuramoto J; Arai E; Tian Y; Funahashi N; Hiramoto M; Nammo T; Nozaki Y; Takahashi Y; Ito N; Shibuya A; Ojima H; Sukeda A; Seki Y; Kasama K; Yasuda K; Kanai Y
Carcinogenesis; 2017 Mar; 38(3):261-270. PubMed ID: 28426876
[TBL] [Abstract][Full Text] [Related]
12. RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients.
Araújo OC; Rosa AS; Fernandes A; Niel C; Villela-Nogueira CA; Pannain V; Araujo NM
PLoS One; 2016; 11(4):e0153796. PubMed ID: 27078152
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of promoter region of SPINT2/HAI-2 gene: an epigenetic mechanism in hepatitis C virus-induced hepatocarcinogenesis.
Ramadan RA; Zaki MA; Awad AM; El-Ghalid LA
Genet Test Mol Biomarkers; 2015 Jul; 19(7):399-404. PubMed ID: 26030814
[TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice.
Chappell G; Kutanzi K; Uehara T; Tryndyak V; Hong HH; Hoenerhoff M; Beland FA; Rusyn I; Pogribny IP
Int J Cancer; 2014 Jun; 134(12):2778-88. PubMed ID: 24242335
[TBL] [Abstract][Full Text] [Related]
15. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
[TBL] [Abstract][Full Text] [Related]
16. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
[TBL] [Abstract][Full Text] [Related]
17. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of DNA methylation in hepatocellular carcinoma.
Sceusi EL; Loose DS; Wray CJ
HPB (Oxford); 2011 Jun; 13(6):369-76. PubMed ID: 21609368
[TBL] [Abstract][Full Text] [Related]
19. Initiation of aberrant DNA methylation patterns and heterogeneity in precancerous lesions of human hepatocellular cancer.
Hlady RA; Zhou D; Puszyk W; Roberts LR; Liu C; Robertson KD
Epigenetics; 2017 Mar; 12(3):215-225. PubMed ID: 28059585
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.
Revill K; Wang T; Lachenmayer A; Kojima K; Harrington A; Li J; Hoshida Y; Llovet JM; Powers S
Gastroenterology; 2013 Dec; 145(6):1424-35.e1-25. PubMed ID: 24012984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]